OXFORD BIOMEDICA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 203 GBX | -0.98% |
|
+0.25% | -7.73% |
| Apr. 18 | Stifel Upgrades Oxford BioMedica to Buy from Hold, Lifts PT | MT |
| Apr. 18 | HSBC likes Haleon, cuts Flutter to 'hold' | AN |
Chart calendar Oxford Biomedica plc
c08353760116340a7273750d6255.e2WXaIwRiBbNks4A_zQ1RUK7SUaoa6O5sAcDJL7CxTk.OT_wK-J15V6Vv70tmlhNInGCBinGOMyIwGlFQY33_Go3K8IEwXXgL4jBhw~9e1daf1290a136b5508e2b9985c44500
Upcoming events on Oxford Biomedica plc
Past events on Oxford Biomedica plc
| 2023-10-10 12:00 am | Cell & Gene Meeting on the Mesa Conference |
| 2023-09-20 08:00 am | Q2 2023 Earnings Call |
| 2023-09-20 02:00 am | Q2 2023 Earnings Release |
| 2023-06-28 | Stifel European Healthcare Summit |
| 2023-06-23 10:00 am | Annual General Meeting |
| 2023-05-17 03:00 pm | ASGCT Meeting |
| 2023-04-25 08:00 am | Q4 2022 Earnings Call |
| 2023-04-25 02:00 am | Q4 2022 Earnings Release |
| 2023-03-26 | SVB Securities Foundations of Discovery, Drugs & Dx Conference |
| 2023-03-15 | JP Morgan Pan-European Small/Mid Cap CEO Conference |
| 2023-01-11 07:30 pm | JP Morgan Healthcare Conference |
| 2022-09-15 08:00 am | Interim 2022 Earnings Call |
| 2022-09-15 02:00 am | Interim 2022 Earnings Release |
| 2022-05-27 10:00 am | Annual General Meeting |
| 2022-04-25 | Chardan Virtual Genetic Medicines and Cell Therapy Manufacturing Summit |
| 2022-04-20 08:00 am | FY 2021 Earnings Call |
| 2022-04-20 02:00 am | FY 2021 Earnings Release |
| 2022-03-08 08:00 am | Shareholders Meeting |
| 2022-01-28 09:00 am | Business Update Call |
| 2021-11-29 | Evercore ISI HealthCONx Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 66,8 70,3 -5.02% | 64,1 69,3 -7.6% | 87,7 85,7 2.35% | 143 156 -8.49% | 140 130 7.41% | 90,5 |
|
EBITDA Million GBP | Released Forecast Spread | 13,4 13,2 1.71% | -5,20 -3,28 -58.68% | 7,30 3,05 139.45% | 35,9 33,8 6.25% | 1,60 -6,65 124.07% | -56,8 |
|
EBIT Million GBP | Released Forecast Spread | 13,9 12,0 15.98% | -14,5 -12,4 -16.58% | -5,69 -7,06 19.38% | 20,8 19,5 6.77% | -30,2 -28,1 -7.4% | -94,9 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 5,01 8,62 -41.81% | -20,9 -18,6 -12.32% | -6,57 -5,94 -10.62% | 19,9 21,2 -6.03% | -46,0 -41,5 -10.73% | -96,0 |
|
Net income Million GBP | Released Forecast Spread | 7,54 9,38 -19.59% | -16,1 -15,9 -0.76% | -6,25 -3,42 -82.6% | 19,0 22,1 -13.78% | -39,2 -44,5 12.01% | -89,4 |
|
EPS GBP | Released Forecast Spread | 0,11 0,14 -19.77% | -0,22 -0,23 1.97% | -0,08 -0,04 -75.9% | 0,22 0,23 -2.69% | -0,41 -0,12 -238.19% | -0,91 |
| Announcement Date | 14/03/19 | 06/05/20 | 15/04/21 | 20/04/22 | 25/04/23 | - |
Quarterly results
| Fiscal Period | December | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 32,1 39,6 -18.85% | 32,0 34,5 -7.37% | 34,0 37,8 -10.19% | 53,7 50,9 5.51% | 81,3 67,5 20.31% | 61,5 75,4 -18.4% | 64,0 61,5 4.19% | 76,0 65,8 15.44% | 43,1 62,0 -30.52% | 47,5 |
|
EBITDA Million GBP | Released Forecast Spread | -1,41 13,4 -110.52% | -3,79 -3,50 -8.29% | -0,40 1,60 -124.88% | 7,70 2,50 208% | 27,1 13,8 96.32% | 8,81 9,20 -4.26% | -5,79 2,00 -389.25% | 7,39 -0,20 3792.5% | -33,7 -10,7 -216.68% | |
|
EBIT Million GBP | Released Forecast Spread | -4,90 8,55 -157.25% | -9,57 -8,10 -18.17% | -5,77 -3,25 -77.42% | 0,07 -3,10 102.32% | 19,7 5,85 236.03% | 1,11 1,80 -38.33% | -19,2 -5,50 -248.31% | -11,1 -18,6 40.52% | -50,7 -30,4 -66.75% | -53,5 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -12,1 4,03 -400.32% | -8,78 -7,20 -21.89% | -6,13 -2,20 -178.45% | -0,45 0,90 -149.56% | 19,2 6,40 200.27% | 0,66 7,80 -91.5% | -27,4 -9,45 -189.78% | -18,6 -24,9 25.33% | -52,3 -30,6 -71.25% | -51,6 |
|
Net income Million GBP | Released Forecast Spread | -10,2 3,25 -412.86% | -5,90 -6,53 9.72% | -6,68 -0,45 -1384.22% | 0,43 1,77 -75.43% | 18,1 5,57 224.59% | 0,94 13,1 -92.81% | -25,5 -10,3 -148.61% | -13,7 -24,4 43.96% | -48,0 -30,9 -55.2% | -48,7 |
|
EPS GBP | Released Forecast Spread | -0,15 0,05 -414.86% | -0,07 -0,09 17.55% | -0,09 -0,01 -1398.28% | 0,01 0,02 -58.35% | 0,21 0,06 229.78% | 0,01 0,08 -89.66% | -0,27 -0,11 -146.41% | -0,14 -0,26 45.1% | -0,50 -0,29 -73.59% | |
| Announcement Date | 04/09/19 | 06/05/20 | 17/09/20 | 15/04/21 | 22/09/21 | 20/04/22 | 15/09/22 | 25/04/23 | 20/09/23 | - |
More events
Past sector events for Oxford Biomedica plc
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OXB Stock
- Calendar Oxford Biomedica plc
